Connect with us

National

Travel Rules Ease, Indian Students See Record Entries To UK Universities – dot newz

Published

on


3,200 students from India have been accepted onto UK universities (Representational)

London:

A record number of 3,200 students from India have been accepted onto UK universities and higher education courses through the country’s centralised application system in 2021, marking an increase of 19 per cent over the previous year.

The Universities and Colleges Admissions Service (UCAS) acceptance figures, released on Tuesday, come days after India was moved off the Red List COVID-19 travel ban on to Amber.

This would have a big impact on Indian students planning to travel to Britain to take up their courses as they no longer need to quarantine in a government-managed facility for 10 days at considerable additional cost.

Instead, they can quarantine for the required 10 days at a chosen destination, which for many will be their university accommodation, or a friend or family home address.

“We know India being moved from the Red to Amber list will be a significant and welcome move for those Indian students due to travel to the UK soon. Those students should stay in touch with their university and be aware of the latest procedure for amber list arrivals to ensure a smooth arrival,” said Vivienne Stern, Director of Universities UK International, which represents over 140 universities.

“UK universities are preparing to give a warm welcome to Indian students this autumn. Students have shown a great amount of patience and resilience in sticking with their plans to study overseas and we look forward to welcoming them, and welcoming them back, to our campuses and university communities,” she said.

India was moved off the Red List at 4 am local time on Sunday and under the Amber List rules, all vaccinated travellers must fill in the compulsory passenger locator form to provide an address where they would be undergoing the 10-day self-isolation.

All Amber List arrivals will need to have a negative COVID-19 test before travelling, as well as take a COVID test on Day 2 and Day 8 of their quarantine. In England, there is the option of paying for a test on Day 5, which if negative, will allow students to end their quarantine early.

“We welcome the news that for one of our largest international markets, India has been moved from the UK’s Red to Amber List,” said Kerry Law, Chief Marketing & Engagement Officer at the University of Leicester – which has a large Indian student population.

“The move to the Amber List is great news for our large number of Indian students and means that alongside no longer needing to quarantine they also won”t have any delays to arrival and can engage and adapt to life on campus,” she said.

“To ensure we welcome students and give them a great experience as we have extended our welcome by an additional week and have developed online transition support for all new starters,” she added.

The National Indian Students and Alumni Union (NISAU) UK had been raising the plight of Indian students facing additional compulsory hotel quarantine costs of 1,750 pounds under the Red List.

It led to Serum Institute of India CEO Adar Poonawalla setting aside Rs 10 crores to assist Indian students who may face additional costs as Covishield – the India-made Oxford/AstraZeneca vaccine – does not fall within the UK-approved vaccines ambit for quarantine-free travel to the UK under the Amber List.

“We are absolutely thrilled to see the numbers of Indian students accepted onto courses via UCAS go up by nearly a fifth as part of the overall significant increase in the numbers choosing to come to the UK to study,” said NISAU UK Chairperson Sanam Arora.

“The UK now offers a wonderful proposition for Indian students – world-class education, a great post-study work offer, and through NISAU a home away from home for Indian students, which I can proudly say is a distinct offering for Indians going abroad to study,” she said.

The UK’s new post-study or Graduate route visa, which came in force in July, offers students the chance to stay on for two years after completing their degree course to be able to gather work experience.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

National

Coronavirus Live News Update: India Creates World Record In Vaccinations With 2.5 Crore Doses In A Day – dot newz

Published

on

By


The government had set out with a target of 2.5 crore vaccinations and crossed the mark by 10,390

India crossed 2.5 crore Covid vaccinations in a day for the first time on Friday as the government raced to deliver a record on Prime Minister Narendra Modi’s birthday. Union Health Minister Mansukh Mandaviya tweeted to confirm the “historic” figure.

The government had set out with a target of 2.5 crore vaccinations and crossed the mark by 10,390.

With 34,403 more people testing positive for COVID-19, India’s overall infection tally has increased to 3,33,81,728, while the count of active cases has dipped to 3,39,056, according to Union health ministry data updated on Friday.

The death count due to the disease has climbed to 4,44,248 with 320 more fatalities being recorded, it said.

The number of active cases now comprises 1.03 per cent of the total infections, while the national COVID-19 recovery rate has been recorded at 97.64 per cent, according to the data updated by the ministry.

It said that active COVID-19 cases in the country decreased by 3,867 cases in a span of 24 hours.

Here are the updates on coronavirus (COVID-19) cases:

Over 7 lakh people vaccinated in Assam on PM’s birthday

A total of 7,09,524 people received the COVID-19 vaccine in Assam on Friday as the state government undertook a mega inoculation drive on the occasion of Prime Minister Narendra Modi’s birthday, a bulletin said.

Over 2.16 crore people have been immunised, and 44.02 lakh of them got both doses of the vaccines, it said.

The special drive was conducted in 4,575 COVID Vaccination Centres (CVCs), of which 4,557 were government sites and 18 private ones.



Source link

Continue Reading

National

WHO Emergency Approval For Covaxin Delayed Till October 5 – dot newz

Published

on

By


The assessment of the SAGE working group on the available pieces of evidence will determine EUA.

New Delhi:

World Health Organisation’s (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.

As per WHO, the Strategic Advisory Group of Experts on Immunization (SAGE) will be meeting on October 5 to granting EUA to Covaxin.

Hanna Nohynek, SAGE member will be introducing session objective setting, an update on regulatory decisions and an overview of Working Group deliverables.

The session will recommend EUA based on the clinical data on Covaxin from phase 1, 2, 3 trial and post-marketing studies on safety, immunogenicity, efficacy and effectiveness.

It will update on global, regional and country-level plans for vaccine safety monitoring.

The assessment of the SAGE working group on the available pieces of evidence will determine EUA.

Meanwhile, Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency.

In a series of tweets, Bharat Biotech said that Covaxin clinical trial was fully compiled and available in June 2021.

“#COVAXIN clinical trial data was fully compiled and available in June 2021. All Data was submitted for Emergency Use Listing (EUL) Application to World Health Organization in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback,” Bharat Biotech tweeted.

As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on the approval process and its timelines, it further said.

“We are continuing to work diligently on obtaining WHO EUL at the earliest,” it added.

Bharat Biotech has submitted its Phase 3 clinical trials data that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

Covaxin was developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology. Covaxin, which has been developed in collaboration with the Indian Council of Medical Research (ICMR), contains a whole virion inactivated SARS-CoV-2 vaccine, which is produced in Vero cells.

The vaccine is stable at 2 degrees Celsius to 8 degrees Celsius (refrigerated) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels.

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)





Source link

Continue Reading

National

PM Praises Frontline, Health Workers As India Administers Over 2 Crore Doses – dot newz

Published

on

By


PM Praises Frontline, Health Workers As India Administers Record Doses

New Delhi:

As India set a new record on Friday by administering over 2 crores COVID-19 vaccine doses, Prime Minister Narendra Modi dedicated the success of the vaccination drive to the country’s doctors, innovators, administrators, nurses, healthcare and all front-line workers.

“Every Indian would be proud of today’s record vaccination numbers. I acknowledge our doctors, innovators, administrators, nurses, healthcare and all front-line workers who have toiled to make the vaccination drive a success. Let us keep boosting vaccination to defeat COVID-19,” PM Modi tweeted.

Bharatiya Janata Party (BJP) and several state governments have aimed to make Prime Minister Narendra Modi’s birthday historic by setting a record number of Covid vaccinations Friday.

Taking to Twitter, Union Health Minister Mansukh Mandaviya said that the historic feat is a gift to PM Modi on behalf of the health workers and the countrymen.

“#VaccineSeva A gift to Prime minister Narendra Modi on behalf of the health workers and the countrymen. Today, on his birthday, India has crossed the historical figure of administering 2 crore vaccines in a day, setting a new record. Well done India!” Mandaviya tweeted.

India has administered more than one crore COVID-19 vaccines in a day on earlier occasions.The vaccination drive in the country commenced on January 16 with the inoculation of healthcare and frontline workers. At present, India is administering COVID-19 vaccines– Covishield of Serum Institute of India (SII), Bharat Biotech”s Covaxin and Sputnik V.

To ramp up the drive, on April 1, the government had opened Covid-19 vaccination for everyone above the age of 45 years. A month later from May 1, as a part of the third phase of the vaccination drive, India began administering the vaccine in the 18 to 44 years age group.

Since then, the country’s vaccination drive is scaling new heights. On August 9, India’s COVID-19 vaccination coverage crossed the landmark of 50 crores.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)





Source link

Continue Reading

Trending

Copyright © 2017 Dot Newz | Developed by MCVP Group 8